摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,6-diethyl-3,6-octanediol | 24459-12-9

中文名称
——
中文别名
——
英文名称
3,6-diethyl-3,6-octanediol
英文别名
3,6-diethyloctane-3,6-diol;3,6-diethyl-octane-3,6-diol;3,6-Diaethyl-octan-3,6-diol;α.α.α'.α'-Tetraaethyl-tetramethylenglykol;3,6-Diethtyl-octandiol-3,6;3,6-Diethyl-3,6-octandiol
3,6-diethyl-3,6-octanediol化学式
CAS
24459-12-9
化学式
C12H26O2
mdl
——
分子量
202.337
InChiKey
MPDCMVBAAPNVSV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    69 °C
  • 沸点:
    154 °C(Press: 12 Torr)
  • 密度:
    0.912±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    14
  • 可旋转键数:
    7
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    40.5
  • 氢给体数:
    2
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2905399090

SDS

SDS:2155a1eaa9668a6d3be454547693aa7c
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3,6-diethyl-3,6-octanediol吡啶 作用下, 以 二氯甲烷 为溶剂, 反应 6.5h, 生成 4,4,7,7-tetraethyl-2-oxo-2-(1-phenylpentyloxy)-1,3,2-dioxaphosphepane
    参考文献:
    名称:
    环状亚磷酰胺及其亚磷酸酯的一些性质:亚磷酸酯化、酯交换和水解
    摘要:
    Phosphorylation of diols using sterically bulky cyclic phosphoramidites was performed in a good selectivity. Their phosphite derivatives underwent tetrazole-catalyzed hydrolysis and transesterification. The reaction was shown to proceed via a phosphorane intermediate by MMR analysis.
    DOI:
    10.3987/com-99-s89
  • 作为产物:
    参考文献:
    名称:
    Salkind; Bystrjakow, Zhurnal Russkago Fiziko-Khimicheskago Obshchestva, 1915, vol. 47, p. 687
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Octahydroanthracene Compound, Preparation Method and Application Thereof
    申请人:SHENYANG PHARMACEUTICAL UNIVERSITY
    公开号:US20190071393A1
    公开(公告)日:2019-03-07
    An octahydroanthracene compound having the structure shown in formula (I) and (II), preparation method and application thereof are disclosed. The octahydroanthracene compound has a good therapeutic effect on tumors and neurodegenerative diseases. The preparation of the octahydroanthracene compound is mainly carried out by using benzene as a starting material, and being subjected to Friedel-Crafts reaction, nitration, reduction, (sulfo-) amide formation, reduction, urea formation or amide formation, thus obtaining a target compound.
    揭示了具有式(I)和(II)所示结构的八氢蒽烷化合物,以及其制备方法和应用。该八氢蒽烷化合物对肿瘤和神经退行性疾病具有良好的治疗效果。该八氢蒽烷化合物的制备主要通过以苯为起始原料,经过弗里德尔-克拉夫斯反应、硝化、还原、(磺酰-)酰胺形成、还原、脲形成或酰胺形成等步骤进行,从而获得目标化合物。
  • Arene-promoted lithiation of 1,n-dihaloalkanes (n=2–6): a comparative study
    作者:Abdeslam Abou、Francisco Foubelo、Miguel Yus
    DOI:10.1016/j.tet.2006.08.064
    日期:2006.10
    n-dichloroalkanes 3a (n=2–6) with an excess of lithium powder and a catalytic amount of 4,4′-di-tert-butylbiphenyl (DTBB; 2.5 mol %) in the presence of different carbonyl compounds [ButCHO, PhCHO, Et2CO, (CH2)4CO, (CH2)5CO, (CH2)7CO, (−)-menthone], in THF at −78 °C leads, after hydrolysis with water, to the expected 1,(n+2)-diols 4, yields being <25% for n=2, 3 and in the range of 45–79% for n=4–6. When the
    1,n-二氯烷烃3a(n = 2–6)与过量的锂粉和催化量的4,4'-二叔丁基联苯(DTBB; 2.5 mol%)在不同羰基存在下的反应化合物[卜吨CHO,苯甲醛,等2 CO,(CH 2)4 CO,(CH 2)5 CO,(CH 2)7 CO,( - ) -薄荷酮],在THF中在-78℃下引线,后用水水解,以期望的1,(ñ 2)-diols 4,产率是<25%ñ = 2,3和为45-79%的范围内ñ= 4–6。当相同的协议被施加到1,Ñ -bromochloroalkanes 3B和1,Ñ -dibromoalkanes 3C(Ñ = 2-6),二醇4在一般得到较低的产率。
  • Octahydroanthracene compound, preparation method and application thereof
    申请人:SHANDONG XINHUA PHARMACEUTICAL CO., LTD.
    公开号:US10399931B2
    公开(公告)日:2019-09-03
    An octahydroanthracene compound having the structure shown in formula (I) and (II), preparation method and application thereof are disclosed. The octahydroanthracene compound has a good therapeutic effect on tumors and neurodegenerative diseases. The preparation of the octahydroanthracene compound is mainly carried out by using benzene as a starting material, and being subjected to Friedel-Crafts reaction, nitration, reduction, (sulfo-) amide formation, reduction, urea formation or amide formation, thus obtaining a target compound.
    本发明公开了一种具有式(I)和(II)所示结构的八氢蒽化合物及其制备方法和应用。该八氢蒽化合物对肿瘤和神经退行性疾病具有良好的治疗效果。八氢蒽化合物的制备主要是以苯为起始原料,经过弗里德尔-卡夫斯反应、硝化、还原、(磺)酰胺形成、还原、脲形成或酰胺形成等反应,从而得到目标化合物。
  • Dupont, Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, 1913, vol. 156, p. 1624
    作者:Dupont
    DOI:——
    日期:——
  • Carriere, Annales de Chimie (Cachan, France), 1922, vol. <9> 17, p. 122
    作者:Carriere
    DOI:——
    日期:——
查看更多